Please Wait...

Bioclinica Announces Senior Leadership Change

Euan Menzies, Chairman of Board of Directors, Named Executive Chairman and Interim CEO | President and CEO David Herron to Step Down

December 20, 2019

PRINCETON, N.J., December 20, 2019 – Bioclinica, a leading provider of clinical science and
technology expertise to assist the life science industry, today announces that David Herron,
Bioclinica’s President and Chief Executive Officer, will be leaving the company to pursue other
business interests. Euan Menzies, the Chairman of Bioclinica’s Board of Directors, will assume the
role of Executive Chairman and interim Chief Executive Officer. To ensure a seamless transition of
leadership responsibilities, Mr. Herron will remain with the Company in an advisory capacity until
the end of January 2020.
“On behalf of everyone at Bioclinica, I would like to thank David for his significant contributions to
the company,” said Menzies. “During the past several years, Bioclinica has achieved numerous
milestones, including improved financial performance and the broadening of its global presence.
We have an exceptional leadership and employee team; and are now well positioned to accelerate
the pace of investment and growth as we continue to deliver meaningful value for our clients.”

Media Contact

About Bioclinica

Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serve more than 500 pharmaceutical, biotechnology and device organizations – including the top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia.




Media Contact
Nicole Klatsky
+1 (609) 865-5212

Learn more about Bioclinica at and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

With many clinical trials slowed or terminated, investments in new technologies are difficult. Yet, a #CTMS with a…
Bioclinica (2 weeks ago)
With Bioclinica #CTMS, sponsors & CROs have access to a full-featured, scalable system - a single, centralized sour…
Bioclinica (2 weeks ago)
Now available: a DIY #EDC solution. From study start-up to close-out, Bioclinica EDC Solo is an efficient, cost-eff…
Bioclinica (3 weeks ago)
Reduce the number of user requirement iterations and UAT findings during the #IRT build process. With the agile app…
Bioclinica (3 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin…
Bioclinica (4 weeks ago)
According to our recent poll, 45% of respondents had neither a #CTMS nor an #eTMF system, while only 24% had both.…
Bioclinica (4 weeks ago)